FDA approves Novartis drug Cosentyx to treat hidradenitis suppurativa patients Â
Phase III data showed Cosentyx can provide rapid relief from symptoms of hidradenitis suppurativa as early as Week 2
The US Food and Drug Administration...
Inventor gifts tablet press to the University students
The equipment (Tablet Press Machine) can be used in pharmaceutical studies as well as metallurgy and 3D printing
Dr Michael Gamlen, the inventor of Gamlen...
Amgen sues Novartis in US court to block generic osteoporosis, bone cancer drugs
Amgen Inc sued Novartis AG's Sandoz in a federal court in the United States on Monday (May 1), accusing Sandoz's proposed versions of its...
Novartis scraps UK heart attack prevention trial
Novartis is halting a UK-based trial originally planned as part of a partnership with NHS England, a setback in its quest to win wider...
INSIGHT: Generics shortages could get way worse across Europe
When Ignasi Biosca-Reig heard there were generics shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production...
Operating profit set to grow as Novartis prepares to spin off its Sandoz generics business
Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year,...